This analysis uncovers gut microbiota variations in PCOS, emphasizing the role of testosterone and regional factors in understanding the disorder’s complexity.
Gilead’s HIV sales hit $4.7B in Q3, first six-month PrEP approval planned in 2025
Gilead says it’s gaining clinical momentum with plans to grow its HIV franchise and nab an approval for an every-six-month pre-exposure prophylaxis (PrEP) approval. Gilead’s